SynthesisBrazilian journal of otorhinolaryngology
Delayed hearing loss in congenital cytomegalovirus infection: systematic review and meta-analysis.
Synthesis in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aims to evaluate the importance of universal screening for congenital Cytomegalovirus (CMV) infection in newborns using urine PCR to identify asymptomatic cases at birth, with or without early hearing impairment, and to monitor this population for the development of late-onset hearing loss.
methodsThis systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The literature search was conducted through four online databases ‒ PUBMED, PUBMED PMC, BVS/BIREME, and EMBASE ‒ for papers published until January 2025. The Newcastle-Ottawa Scale was used to assess the risk of bias.
resultsThe search strategy identified 824 articles. Following the abstract screening, 22 studies were selected for full-text review, of which three met the criteria for data synthesis. All three studies were prospective, applied universal CMV screening through urine PCR, and followed patients with auditory brainstem response for at least four years. A meta-analysis was performed using a random-effects model with inverse-variance weighting and the Restricted Maximum Likelihood estimator. Among the three studies included in the assessment, 56,892 newborns were screened with urine samples. The meta-analysis found a proportion of prevalence of congenital CMV infection of 0.46%. The proportions of asymptomatic cases and late hearing impairment was 83.4% and 13.9%, respectively. Additionally, early hearing impairment was detected in 22 (12%) newborns, and one study demonstrated that 11% of asymptomatic patients developed long-term neurological sequelae in addition to hearing loss.
conclusionOur meta-analysis evaluated epidemiological aspects of hearing loss associated with cCMV infection and found that a significant proportion of infants with asymptomatic infection develop late-onset hearing loss. The absence of structured screening risks missing these patients in long-term follow-up and may increase costs related to delayed diagnosis and investigation. LEVEL OF EVIDENCE: Level 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.